🇺🇸 FDA
Patent

US 7276348

Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof

granted A61KA61K31/551A61K31/5513

Quick answer

US patent 7276348 (Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/551, A61K31/5513